CSMCi001-A-1

CS011iMEN1-n4.Homo5

The cell line is not validated yet.

General

Cell Line

hPSCreg Name
CSMCi001-A-1
Alternative name(s)
CS011iMEN1-n4.Homo5
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 15th February 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Cedars Sinai Medical Center, (CSMC)

External Databases

BioSamples SAMEA112648669
CLO CLO_0104321

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
multiple endocrine neoplasia type 1
The donor is a carrier of a disease-associated mutation and affected.

External Databases (Donor)

BioSamples SAMEA112648427

Ethics

Also have a look at the ethics information for the parental line CSMCi001-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line CSMCi001-A.

Reprogramming method

Vector type None

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ Plus

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line CSMCi001-A .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
multiple endocrine neoplasia type 1
Genetic modifications
MEN1 (target)
Isogenic modification
11q13
Homozygous
Mutated
Genetic modifications not related to a disease